In a very recent work, PLGA-based nanoparticles were functionalized with hyaluronic acid of different weights (200, 800, and 1437 kDa) and their targeting properties were evaluated on CD44-overexpressing cancer cells [188]. This evidence concerns the gene CD44 and cancer.